Plasticity of ether lipids promotes ferroptosis susceptibility and evasion

• Published in: Nature (London) Vol. 585; no. 7826; pp. 603 - 608
• Main Authors: Zou, Yilong, Henry, Whitney S., Ricq, Emily L., Graham, Emily T., Phadnis, Vaishnavi V., Maretich, Pema, Paradkar, Sateja, Boehnke, Natalie, Deik, Amy A., Reinhardt, Ferenc, Eaton, John K., Ferguson, Bryan, Wang, Wenyu, Fairman, Joshua, Keys, Heather R., Dančík, Vlado, Clish, Clary B., Clemons, Paul A., Hammond, Paula T., Boyer, Laurie A., Weinberg, Robert A., Schreiber, Stuart L.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 24.09.2020; Nature Publishing Group
• Subjects: 13; 14; 14/34; 45; 45/41; 45/91; 631/45/608; 631/67/2327; 631/80/642/2013; 631/80/82; 631/92/287/1194; 64; 64/60; 82/58; Analysis; Animals; Apoptosis; Biosynthesis; Cancer; Cardiomyocytes; Cell death; Cell Differentiation; Cell Line; CRISPR; CRISPR-Cas Systems - genetics; Enzymes; Ether lipids; Ethers - chemistry; Ethers - metabolism; Female; Ferroptosis; Gene Editing; Genes; Genetic susceptibility; Genomes; Glycerol; Humanities and Social Sciences; Humans; Influence; Kidney Neoplasms - metabolism; Kidney Neoplasms - pathology; Lipid Peroxidation; Lipids; Male; Mice; multidisciplinary; Myocytes, Cardiac - cytology; Myocytes, Cardiac - metabolism; Nanoparticles; Neurons - cytology; Neurons - metabolism; Organelles; Ovarian cancer; Ovarian carcinoma; Ovarian Neoplasms - metabolism; Ovarian Neoplasms - pathology; Ovaries; Peroxidation; Peroxisomes; Peroxisomes - genetics; Peroxisomes - metabolism; Phospholipids; Phospholipids - chemistry; Phospholipids - metabolism; Plasticity; Properties; Renal cell carcinoma; Science; Science (multidisciplinary); Substrates; Susceptibility; Therapeutic applications; United States
• ISSN: 0028-0836; 1476-4687; 1476-4687
• DOI: 10.1038/s41586-020-2732-8

Ferroptosis—an iron-dependent, non-apoptotic cell death process—is involved in various degenerative diseases and represents a targetable susceptibility in certain cancers 1 . The ferroptosis-susceptible cell state can either pre-exist in cells that arise from certain lineages or be acquired during cell-state transitions 2 – 5 . However, precisely how susceptibility to ferroptosis is dynamically regulated remains poorly understood. Here we use genome-wide CRISPR–Cas9 suppressor screens to identify the oxidative organelles peroxisomes as critical contributors to ferroptosis sensitivity in human renal and ovarian carcinoma cells. Using lipidomic profiling we show that peroxisomes contribute to ferroptosis by synthesizing polyunsaturated ether phospholipids (PUFA-ePLs), which act as substrates for lipid peroxidation that, in turn, results in the induction of ferroptosis. Carcinoma cells that are initially sensitive to ferroptosis can switch to a ferroptosis-resistant state in vivo in mice, which is associated with extensive downregulation of PUFA-ePLs. We further find that the pro-ferroptotic role of PUFA-ePLs can be extended beyond neoplastic cells to other cell types, including neurons and cardiomyocytes. Together, our work reveals roles for the peroxisome–ether-phospholipid axis in driving susceptibility to and evasion from ferroptosis, highlights PUFA-ePL as a distinct functional lipid class that is dynamically regulated during cell-state transitions, and suggests multiple regulatory nodes for therapeutic interventions in diseases that involve ferroptosis. The cellular organelles peroxisomes contribute to the sensitivity of cells to ferroptosis by synthesizing polyunsaturated ether phospholipids, and changes in the abundances of these lipids are associated with altered sensitivity to ferroptosis during cell-state transitions.